Moderate Evidence (L3-L4)
Candidates with preliminary evidence that require further validation
Criteria
| Level | Definition | Clinical meaning |
|---|---|---|
| L3 | Observational studies / large case series | Preliminary support; needs further validation |
| L4 | Preclinical / mechanistic studies | Theoretical support; far from clinical use |
L3 (57 drugs)
| Drug | Indications | Link |
|---|---|---|
| Acetylsalicylic Acid | 9 | View report |
| Adalimumab | 6 | View report |
| Alitretinoin | 10 | View report |
| Almotriptan | 3 | View report |
| Alprazolam | 3 | View report |
| Alteplase | 9 | View report |
| Anagrelide | 2 | View report |
| Baclofen | 2 | View report |
| Bumetanide | 1 | View report |
| Cefradine | 10 | View report |
| Clofazimine | 3 | View report |
| Clonazepam | 3 | View report |
| Cyclosporine | 7 | View report |
| Danazol | 10 | View report |
| Duloxetine | 10 | View report |
| Emtricitabine | 3 | View report |
| Eucalyptus Oil | 10 | View report |
| Famotidine | 10 | View report |
| Fluphenazine | 10 | View report |
| Frovatriptan | 3 | View report |
| Hydroquinone | 10 | View report |
| Hydroxyzine | 5 | View report |
| Imipramine | 7 | View report |
| Indoramin | 10 | View report |
| Ketamine | 1 | View report |
| Lacosamide | 10 | View report |
| Mebendazole | 10 | View report |
| Melphalan | 10 | View report |
| Meropenem | 10 | View report |
| Mesalazine | 7 | View report |
| Mexiletine | 10 | View report |
| Micafungin | 10 | View report |
| Miconazole | 1 | View report |
| Naratriptan | 3 | View report |
| Nicotinamide | 10 | View report |
| Nitisinone | 10 | View report |
| Nitrazepam | 3 | View report |
| Nystatin | 10 | View report |
| Ofloxacin | 10 | View report |
| Olanzapine | 3 | View report |
| Oxazepam | 1 | View report |
| Oxcarbazepine | 10 | View report |
| Phenytoin | 10 | View report |
| Posaconazole | 10 | View report |
| Prednisone | 10 | View report |
| Pristinamycin | 10 | View report |
| Progesterone | 10 | View report |
| Propafenone | 8 | View report |
| Rifampicin | 10 | View report |
| Ritonavir | 3 | View report |
| Stanozolol | 10 | View report |
| Teicoplanin | 10 | View report |
| Tenofovir Disoproxil | 4 | View report |
| Thiamine | 10 | View report |
| Tiagabine | 1 | View report |
| Tranexamic Acid | 1 | View report |
| Tryptophan | 10 | View report |
L4 (97 drugs)
| Drug | Indications | Link |
|---|---|---|
| Abacavir | 3 | View report |
| Acetic Acid | 10 | View report |
| Acitretin | 4 | View report |
| Allopurinol | 10 | View report |
| Amikacin | 10 | View report |
| Aminophylline | 10 | View report |
| Ampicillin | 10 | View report |
| Apixaban | 10 | View report |
| Arginine | 1 | View report |
| Bendroflumethiazide | 5 | View report |
| Betaxolol | 1 | View report |
| Bicalutamide | 10 | View report |
| Biotin | 2 | View report |
| Bosentan | 9 | View report |
| Budesonide | 10 | View report |
| Buprenorphine | 6 | View report |
| Buserelin | 5 | View report |
| Cabergoline | 5 | View report |
| Caffeine | 10 | View report |
| Camphor | 10 | View report |
| Candesartan Cilexetil | 5 | View report |
| Captopril | 4 | View report |
| Carbamazepine | 10 | View report |
| Carvedilol | 5 | View report |
| Certolizumab Pegol | 6 | View report |
| Chenodeoxycholic Acid | 5 | View report |
| Ciprofloxacin | 10 | View report |
| Clobazam | 10 | View report |
| Clotrimazole | 10 | View report |
| Cyanocobalamin | 1 | View report |
| Cyclizine | 10 | View report |
| Cyproheptadine | 4 | View report |
| Dapoxetine | 3 | View report |
| Darunavir | 4 | View report |
| Deferasirox | 5 | View report |
| Deferiprone | 9 | View report |
| Desogestrel | 10 | View report |
| Diethylstilbestrol | 3 | View report |
| Dimethicone | 10 | View report |
| Dipyridamole | 10 | View report |
| Dorzolamide | 10 | View report |
| Doxycycline | 10 | View report |
| Efavirenz | 3 | View report |
| Eletriptan | 4 | View report |
| Eltrombopag | 1 | View report |
| Entecavir | 10 | View report |
| Erythromycin | 10 | View report |
| Esomeprazole | 3 | View report |
| Ethambutol | 5 | View report |
| Etonogestrel | 5 | View report |
| Etoposide | 10 | View report |
| Etravirine | 10 | View report |
| Felodipine | 7 | View report |
| Filgrastim | 10 | View report |
| Flunisolide | 10 | View report |
| Fluoxetine | 10 | View report |
| Flutamide | 10 | View report |
| Fusidic Acid | 10 | View report |
| Gemfibrozil | 10 | View report |
| Glucagon | 1 | View report |
| Golimumab | 5 | View report |
| Griseofulvin | 5 | View report |
| Hyaluronidase | 10 | View report |
| Hydromorphone | 6 | View report |
| Isoniazid | 1 | View report |
| Lansoprazole | 2 | View report |
| Lenograstim | 4 | View report |
| Levetiracetam | 10 | View report |
| Levofloxacin | 10 | View report |
| Lisinopril | 10 | View report |
| Methylcellulose | 10 | View report |
| Metipranolol | 3 | View report |
| Minoxidil | 10 | View report |
| Misoprostol | 2 | View report |
| Modafinil | 1 | View report |
| Nalidixic Acid | 4 | View report |
| Nevirapine | 3 | View report |
| Nilotinib | 1 | View report |
| Oxitriptan | 10 | View report |
| Permethrin | 10 | View report |
| Pimozide | 10 | View report |
| Pramipexole | 10 | View report |
| Prasugrel | 10 | View report |
| Pregabalin | 6 | View report |
| Probenecid | 3 | View report |
| Propylthiouracil | 3 | View report |
| Prucalopride | 10 | View report |
| Quetiapine | 10 | View report |
| Ribavirin | 10 | View report |
| Rivastigmine | 1 | View report |
| Selenium | 1 | View report |
| Sulfadiazine | 10 | View report |
| Sumatriptan | 1 | View report |
| Tobramycin | 10 | View report |
| Tramadol | 10 | View report |
| Trifluoperazine | 1 | View report |
| Valsartan | 7 | View report |
Disclaimer
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)